[6-K] Lloyds Banking Group plc Current Report (Foreign Issuer)
Rhea-AI Filing Summary
Lloyds Banking Group reports it purchased 5,091,816 ordinary shares on 19 September 2025 as part of its ongoing share buyback programme. The purchases were made through Morgan Stanley & Co. International plc with a volume weighted average price of 82.1442 pence, a highest price of 83.3800 pence and a lowest price of 81.4800 pence. These purchases were effected under instructions issued on 20 February 2025 and previously announced on 21 February 2025. The Company intends to cancel the bought-back shares. A full trade breakdown is available in the linked schedule.
Positive
- Execution of buyback: 5,091,816 shares repurchased, showing active capital return under the existing programme
- Cancellation intent: Company intends to cancel the repurchased shares, which will reduce share count
- Regulatory transparency: Detailed trade breakdown provided and reported in line with Market Abuse Regulation
Negative
- None.
Insights
TL;DR: Lloyds executed a routine buyback of 5.09m shares at ~82.14p, to be cancelled, reducing share count modestly.
The purchase is a straightforward execution of an existing buyback programme, acquiring 5,091,816 ordinary shares via a broker at a VWAP of 82.1442 pence. Cancellation of the shares will reduce the company’s issued share capital, which is typically accretive to underlying EPS assuming constant earnings. The announcement confirms compliance with Market Abuse Regulation reporting and references the original instruction date of 20 February 2025. No other financial results or guidance are provided in this filing.
TL;DR: The buyback was executed under pre-authorized instructions and follows standard disclosure and cancellation practice.
The filing documents a routine corporate action under an approved buyback programme with transparent trade reporting. The company explicitly states intent to cancel the repurchased shares, which aligns with capital management practices to return value to shareholders. The disclosure includes trade price range and VWAP and points investors to a detailed schedule for individual trades, meeting regulatory transparency requirements. No governance concerns or deviations are indicated in this notice.